Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.18/5072
Título: 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project
Autor: Rondy, Marc
Larrauri, Amparo
Casado, Itziar
Alfonsi, Valeria
Pitigoi, Daniela
Launay, Odile
Syrjänen, Ritva K
Gefenaite, Giedre
Machado, Ausenda
Vučina, Vesna Višekruna
Horváth, Judith Krisztina
Paradowska-Stankiewicz, Iwona
Marbus, Sierk D
Gherasim, Alin
Díaz-González, Jorge Alberto
Rizzo, Caterina
Ivanciuc, Alina E
Galtier, Florence
Ikonen, Niina
Mickiene, Aukse
Gomez, Veronica
Kurečić Filipović, Sanja
Ferenczi, Annamária
Korcinska, Monika R
van Gageldonk-Lafeber, Rianne
I-MOVE+ hospital working group
Valenciano, Marta
Palavras-chave: Case Control
Elderly
Influenza
Hospitalisation
Severe Acute Respiratory Infection
Vaccine Effectiveness
Vaccine-preventable Diseases
Efetividade da Vacina Antigripal
Hospital
Vacina Antigripal
Cuidados de Saúde
Infecções Respiratórias
Data: 30-Jul-2017
Editora: European Centre for Disease Prevention and Control
Citação: Euro Surveill. 2017 Jul 27;22(30) pii: 30580. doi: 10.2807/1560-7917.ES.2017.22.30.30580
Resumo: We conducted a multicentre test-negative case-control study in 27 hospitals of 11 European countries to measure 2015/16 influenza vaccine effectiveness (IVE) against hospitalised influenza A(H1N1)pdm09 and B among people aged ≥ 65 years. Patients swabbed within 7 days after onset of symptoms compatible with severe acute respiratory infection were included. Information on demographics, vaccination and underlying conditions was collected. Using logistic regression, we measured IVE adjusted for potential confounders. We included 355 influenza A(H1N1)pdm09 cases, 110 influenza B cases, and 1,274 controls. Adjusted IVE against influenza A(H1N1)pdm09 was 42% (95% confidence interval (CI): 22 to 57). It was 59% (95% CI: 23 to 78), 48% (95% CI: 5 to 71), 43% (95% CI: 8 to 65) and 39% (95% CI: 7 to 60) in patients with diabetes mellitus, cancer, lung and heart disease, respectively. Adjusted IVE against influenza B was 52% (95% CI: 24 to 70). It was 62% (95% CI: 5 to 85), 60% (95% CI: 18 to 80) and 36% (95% CI: -23 to 67) in patients with diabetes mellitus, lung and heart disease, respectively. 2015/16 IVE estimates against hospitalised influenza in elderly people was moderate against influenza A(H1N1)pdm09 and B, including among those with diabetes mellitus, cancer, lung or heart diseases.
Descrição: Members of the I-MOVE+ project - Portugal: Baltazar Nunes, Ana Paula Rodrigues, Raquel Guiomar (Infectious Diseases Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal), Victor Gomes, Filipa Quaresma, Luis Vale, Teresa Garcia, Teresa Bernardo, Liliana Dias, Paula Fonseca, Helena Amorim, João Rolo, Helena Pacheco, Paula Branquinho, Rita Côrte-Real (Centro Hospitalar de Lisboa Central, Lisbon, Portugal),José Poças, Paula Lopes, Maria João Peres, Rosa Ribeiro, Paula Duarte, Ermelinda Pedroso, Sara Rodrigues, Ana Rita Silvério, Diana Gomes Pedreira, Marta Ferreira Fonseca, (Centro Hospitalar de Setúbal, Setúbal, Portugal).
Peer review: yes
URI: http://hdl.handle.net/10400.18/5072
DOI: 10.2807/1560-7917.ES.2017.22.30.30580
ISSN: 1025-496X
Versão do Editor: http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2017.22.30.30580
Aparece nas colecções:DDI - Artigos em revistas internacionais
DEP - Artigos em revistas internacionais

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Rondy_2015_16 seasonal vaccine effectiveness against.pdf546,6 kBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.